PeptideDB

Cetaben 55986-43-1

Cetaben 55986-43-1

CAS No.: 55986-43-1

Cetaben is a PPARα-independent peroxisome proliferator. Cetaben is a non-fibrotic hypolipidemic agent that effectively
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Cetaben is a PPARα-independent peroxisome proliferator. Cetaben is a non-fibrotic hypolipidemic agent that effectively reduces cholesterol and triglyceride concentrations.

Physicochemical Properties


Molecular Formula C23H39NO2
Molecular Weight 361.56126
Exact Mass 361.298
CAS # 55986-43-1
Related CAS # 55986-43-1;64059-66-1 (Na+);
PubChem CID 47263
Appearance White to off-white solid powder
Density 1.0±0.1 g/cm3
Boiling Point 503.4±33.0 °C at 760 mmHg
Flash Point 258.3±25.4 °C
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.521
LogP 9.68
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 17
Heavy Atom Count 26
Complexity 324
Defined Atom Stereocenter Count 0
InChi Key QXWKHSSBFQDQPR-UHFFFAOYSA-N
InChi Code

InChI=1S/C23H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20-24-22-18-16-21(17-19-22)23(25)26/h16-19,24H,2-15,20H2,1H3,(H,25,26)
Chemical Name

4-(hexadecylamino)benzoic acid
Synonyms

Cetaben
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro HepG2 and MH1C1 cells undergo substantial micromorphological and ultrastructural alterations when exposed to cetaben (10 µM) for a whole day. Following exposure to 100 µM cetaben, cells have several Golgi regions, the majority of which break down into vesicles [2]. Significant variety in the peroxisomal population is observed in cells treated with Cetaben (10 µM; 24 hours); dumbbell- and cup-shaped peroxisomal features develop in MH1C1 cells [2].
ln Vivo During the course of ten days, Cetaben, at dosages ranging from 50 to 100 mg/kg body weight, significantly increased the activity of peroxisomal enzymes in the liver and kidneys; however, the highest effect was noted at a dose of 250 mg/kg [1].
Animal Protocol Animal/Disease Models: Male Wistar rat[1] Doses: 10, 25, 50, 100, 250 and 500 mg/kg
Route of Administration: gavage; 10-day
Experimental Results: At doses of 50-100 mg/kg body weight, 10 The activity of peroxisomal enzymes in the liver and kidneys increased Dramatically after days, but the maximum effect was observed at the 250 mg/kg dose.
References

[1]. Cetaben and fibrates both influence the activities of peroxisomal enzymes in different ways. Biochem Pharmacol. 1994 Feb 9;47(3):515-9.

[2]. Cetaben-induced changes on the morphology and peroxisomal enzymes in MH1C1 rat hepatomacells and HepG2 human hepatoblastoma cells. Histochem Cell Biol. 2001 Jun;115(6):509-19.

Additional Infomation Cetaben is a unique, PPARalpha-independent peroxisome proliferator with hypolipidemic activity. Cetaben decreases serum cholesterol levels by inhibiting cholesterol biosynthesis.

Solubility Data


Solubility (In Vitro) DMSO : ~25 mg/mL (~69.14 mM)
Solubility (In Vivo) Solubility in Formulation 1: 2.5 mg/mL (6.91 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (6.91 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.7658 mL 13.8290 mL 27.6579 mL
5 mM 0.5532 mL 2.7658 mL 5.5316 mL
10 mM 0.2766 mL 1.3829 mL 2.7658 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.